|
TMEM182 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.539300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.582000E-02 |
| Normal-vs-Stage2 |
3.003000E-01 |
| Normal-vs-Stage3 |
1.220130E-02 |
| Normal-vs-Stage4 |
1.641110E-04 |
| Stage1-vs-Stage2 |
5.267800E-01 |
| Stage1-vs-Stage3 |
2.562400E-01 |
| Stage1-vs-Stage4 |
9.600700E-03 |
| Stage2-vs-Stage3 |
2.134000E-01 |
| Stage2-vs-Stage4 |
3.362000E-02 |
| Stage3-vs-Stage4 |
3.461200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.217200E-03 |
| Normal-vs-AfricanAmerican |
9.442900E-04 |
| Normal-vs-Asian |
4.199000E-01 |
| Caucasian-vs-AfricanAmerican |
1.102170E-01 |
| Caucasian-vs-Asian |
9.164400E-01 |
| AfricanAmerican-vs-Asian |
4.037400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.739840E-02 |
| Normal-vs-Female |
5.197600E-04 |
| Male-vs-Female |
1.670390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.138900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.816100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.356040E-02 |
| Normal-vs-Age(81-100Yrs) |
1.007810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.442400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.394410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.815400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.624000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.742600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.714400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.110100E-02 |
| Normal-vs-Grade 2 |
5.422500E-02 |
| Normal-vs-Grade 3 |
5.720100E-03 |
| Normal-vs-Grade 4 |
3.57130000000483E-05 |
| Grade 1-vs-Grade 2 |
5.034000E-01 |
| Grade 1-vs-Grade 3 |
7.723200E-01 |
| Grade 1-vs-Grade 4 |
2.561600E-01 |
| Grade 2-vs-Grade 3 |
5.043000E-01 |
| Grade 2-vs-Grade 4 |
2.381200E-03 |
| Grade 3-vs-Grade 4 |
8.044900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.790400E-02 |
| Normal-vs-ccB subtype |
5.512000E-02 |
| ccA subtype-vs-ccB subtype |
7.172600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.586200E-02 |
| Normal-vs-N1 |
3.167000E-01 |
| N0-vs-N1 |
9.109800E-01 |
|
|
